BR9914092A - Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporina - Google Patents
Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporinaInfo
- Publication number
- BR9914092A BR9914092A BR9914092-6A BR9914092A BR9914092A BR 9914092 A BR9914092 A BR 9914092A BR 9914092 A BR9914092 A BR 9914092A BR 9914092 A BR9914092 A BR 9914092A
- Authority
- BR
- Brazil
- Prior art keywords
- csa
- cyclosporine
- polyclonal
- antibodies
- metabolites
- Prior art date
Links
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical group CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 15
- 108010036949 Cyclosporine Proteins 0.000 title abstract 6
- 229960001265 ciclosporin Drugs 0.000 title abstract 6
- 229930182912 cyclosporin Natural products 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 230000001900 immune effect Effects 0.000 abstract 3
- 239000002207 metabolite Substances 0.000 abstract 3
- 229930105110 Cyclosporin A Natural products 0.000 abstract 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9493—Immunosupressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"PROCESSOS PARA A PRODUçãO DE ANTICORPOS A REGIõES ESPECìFICAS DE CICLOSPORINA E METABóLITOS DE CICLOSPORINA" A presente invenção se refere à produção de anticorpos policlonais e monoclonais a regiões específicas de ciclosporina (CSA) e/ou metabólitos/derivados de CSA. A reatividade destes anticorpos policlonais e monoclonais torna-os especialmente úteis para testes imunológicos para a monitoração de medicamentos terapêuticos (TDM). Estes testes imunológicos ou kits TDM podem incluir anticorpos policlonais e monoclonais a sítios específicos de CSA e/ou de metabólicos de CSA. Estes kits podem também incluir diversas combinações de anticorpos policlonais, anticorpos policlonais e monoclonais ou a um painel de anticorpos monoclonais. Os imunógenos de ciclosporina ou de conjugado de metabólitos de CSA são preparados para a imunização de um animal hospedeiro e para produzir anticorpos dirigidos a regiões específicas de CSA ou da molécula de metabólito de CSA. Por determinação da região de ligação específica de um anticorpo específicos, são desenvolvidos os testes imunológicos que são capazes de distinguir entre a molécula genitora, os metabólitos ativos, metabólitos inativos e outros compostos imunossupressores de estrutura análoga. é descrito o emprego de divinil sulfona (DVS) como molécula de braço de linker para a formação de imunógenos de ciclosporina e de conjugado de proteína de metabólito de ciclosporina.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16888598A | 1998-10-09 | 1998-10-09 | |
| US09/390,280 US6686454B1 (en) | 1998-10-09 | 1999-09-03 | Antibodies to specific regions of cyclosporine related compounds |
| PCT/CA1999/000930 WO2000022000A1 (en) | 1998-10-09 | 1999-10-08 | Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9914092A true BR9914092A (pt) | 2001-06-12 |
Family
ID=26864555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9914092-6A BR9914092A (pt) | 1998-10-09 | 1999-10-08 | Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporina |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6713266B1 (pt) |
| EP (1) | EP1121383A1 (pt) |
| JP (1) | JP3595506B2 (pt) |
| CN (1) | CN1319105A (pt) |
| AU (1) | AU763822B2 (pt) |
| BR (1) | BR9914092A (pt) |
| CA (1) | CA2343356A1 (pt) |
| WO (1) | WO2000022000A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2380219T3 (es) * | 2004-08-13 | 2012-05-09 | Wyeth Llc | Metabolitos, derivados de tanaproget, y sus utilizaciones |
| US20090170218A1 (en) * | 2008-01-02 | 2009-07-02 | Dade Behring Inc. | Methods for detection of cyclosporin a |
| US8586322B2 (en) * | 2012-03-07 | 2013-11-19 | Siemens Healthcare Diagnostics, Inc | Sandwich assay for immunosuppressant drugs |
| EP3234607B1 (en) * | 2014-12-17 | 2021-04-28 | Siemens Healthcare Diagnostics Inc. | Sandwich assay design for small molecules |
| CN104764883A (zh) * | 2015-03-31 | 2015-07-08 | 上海云泽生物科技有限公司 | 一种检测环孢霉素a浓度的免疫分析方法和试剂盒 |
| JP6879496B2 (ja) | 2015-10-29 | 2021-06-02 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | 小分子のためのサンドイッチアッセイ |
| CN108794621A (zh) * | 2017-05-04 | 2018-11-13 | 南开大学 | 环孢霉素的偶联物及其制备方法与应用 |
| CN110174363A (zh) * | 2019-01-09 | 2019-08-27 | 北京九强生物技术股份有限公司 | 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587342T2 (de) * | 1984-10-04 | 1993-12-02 | Sandoz Ag | Cyclosporine. |
| US5169773A (en) | 1984-10-04 | 1992-12-08 | Sandoz Ltd. | Monoclonal antibodies to cyclosporins |
| EP0283801A3 (en) * | 1987-03-27 | 1990-05-30 | Abbott Laboratories | Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies |
| US4914188A (en) | 1987-11-16 | 1990-04-03 | Merck & Co., Inc. | Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
| WO1990006763A1 (en) * | 1988-12-05 | 1990-06-28 | The Trustees Of Columbia University In The City Of New York | Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof |
| US5604092A (en) * | 1988-12-05 | 1997-02-18 | The Trustees Of Columbia University In The City Of New York | Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein |
| DE69133095T2 (de) | 1990-11-20 | 2003-03-27 | Dade Behring Marburg Gmbh | Cyclosporin-Immunoassay |
| JP3340434B2 (ja) * | 1991-07-04 | 2002-11-05 | ダコ アクティーゼルスカブ | ジビニルスルホンに由来する成分を含んで成る水溶性ポリマーベース試薬及び抱合体 |
| US6106828A (en) | 1996-02-15 | 2000-08-22 | Novo Nordisk A/S | Conjugation of polypeptides |
| US6309646B1 (en) * | 1996-05-09 | 2001-10-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates |
| JP2001518784A (ja) * | 1997-04-09 | 2001-10-16 | アイソテクニカ，インコーポレイテッド | ラパマイシンの特異的部位に対する抗体の産生方法 |
-
1999
- 1999-10-08 BR BR9914092-6A patent/BR9914092A/pt not_active IP Right Cessation
- 1999-10-08 AU AU59649/99A patent/AU763822B2/en not_active Ceased
- 1999-10-08 CN CN99811136A patent/CN1319105A/zh active Pending
- 1999-10-08 CA CA002343356A patent/CA2343356A1/en not_active Abandoned
- 1999-10-08 WO PCT/CA1999/000930 patent/WO2000022000A1/en not_active Ceased
- 1999-10-08 JP JP2000575902A patent/JP3595506B2/ja not_active Expired - Fee Related
- 1999-10-08 EP EP99970400A patent/EP1121383A1/en not_active Withdrawn
-
2000
- 2000-08-30 US US09/650,684 patent/US6713266B1/en not_active Expired - Fee Related
-
2004
- 2004-01-13 US US10/757,377 patent/US20040198952A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20040198952A1 (en) | 2004-10-07 |
| CA2343356A1 (en) | 2000-04-20 |
| CN1319105A (zh) | 2001-10-24 |
| AU763822B2 (en) | 2003-07-31 |
| EP1121383A1 (en) | 2001-08-08 |
| JP2002527454A (ja) | 2002-08-27 |
| US6713266B1 (en) | 2004-03-30 |
| WO2000022000A1 (en) | 2000-04-20 |
| JP3595506B2 (ja) | 2004-12-02 |
| AU5964999A (en) | 2000-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12203938B2 (en) | Levetiracetam immunoassays | |
| HK1039340A1 (zh) | 向cyclosporine及cyclosporine代謝產物的特別位置生產抗體的方法 | |
| US20240192236A1 (en) | Compounds and Methods for Use in Detecting Gabapentin | |
| US11703514B2 (en) | Pregabalin immunoassays | |
| US20140206020A1 (en) | Voriconazole Immunoassays | |
| JPS6120867A (ja) | 抗体‐レクチンのサンドイツチ検定 | |
| JP2592121B2 (ja) | ＩｇＡ腎臓病の診断のための方法及びキツト | |
| FI961004A0 (fi) | Määrityspakkaus | |
| BR9914092A (pt) | Processos para a produção de anticorpos a regiões especìficas de ciclosporina e metabólitos de ciclosporina | |
| US5367058A (en) | Modified antibodies with increased affinity | |
| US20140227717A1 (en) | Posaconazole Immunoassays | |
| US6306616B1 (en) | Adsorption type confirmatory assays | |
| Parham | Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies. | |
| Du et al. | Preparation of steroid antibodies and parallel detection of multianabolic steroid abuse with conjugated hapten microarray | |
| JP2732825B2 (ja) | 新規なベンゾジアゼピン−タンパク質結合体 | |
| WO1998026644A9 (en) | Confirmatory assays for small molecule drugs | |
| JPH10265457A (ja) | インドキシル硫酸誘導体、抗原、抗体及びそれを用いるインドキシル硫酸の検出方法 | |
| EP2698383B1 (en) | Detection of synthetic Cannabinoids | |
| JPH0727763A (ja) | １α，２５（ＯＨ）２ビタミンＤ３に対する抗体及びその用途 | |
| JP3408158B2 (ja) | スルトプリド誘導体及び抗スルトプリド抗体 | |
| JP3510889B2 (ja) | 糖尿病及び前糖尿症状の診断のための方法 | |
| JP3973424B2 (ja) | テルビナフィンに対する特異的モノクローナル抗体 | |
| JP3709078B2 (ja) | ジアセチルポリアミンの測定法及びキット | |
| JP3453522B2 (ja) | ピルメノール誘導体及び抗ピルメノール抗体 | |
| Irnaten et al. | Prediction of epitopes and production of monoclonal antibodies against gastric H, K-ATPase. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1999 DE 28/04/2009. |